What is Lumasiran: Uses, Dosage, Side Effects and More

Lumasiran is a specialized medication designed to help people with a rare genetic condition called primary hyperoxaluria type 1 (PH1). This injectable medicine works by reducing the amount of oxalate your body produces, which can help prevent painful kidney stones and protect your kidneys from damage.

If you or someone you care about has been diagnosed with PH1, you're likely feeling overwhelmed with questions and concerns. This condition affects how your body processes certain substances, leading to a buildup of oxalate that can cause serious kidney problems. The good news is that lumasiran represents a significant breakthrough in treating this challenging condition, offering hope and improved quality of life for many patients.

What is Lumasiran?

Lumasiran is a prescription medication that belongs to a class of drugs called RNA interference (RNAi) therapeutics. It works by "silencing" specific genes in your liver that are responsible for producing too much oxalate in people with PH1.

Think of lumasiran as a precise molecular tool that targets the root cause of your condition rather than just treating the symptoms. The medication is given as a subcutaneous injection, which means it's injected under the skin, similar to how people with diabetes give themselves insulin shots. This targeted approach helps your body produce significantly less oxalate, reducing the risk of kidney stone formation and kidney damage.

The medication was developed specifically for people with primary hyperoxaluria type 1, a rare genetic disorder that affects fewer than 3 people per million worldwide. Having such a specialized treatment available represents a major advancement in caring for people with this condition.

What is Lumasiran Used For?

Lumasiran is specifically approved to treat primary hyperoxaluria type 1 (PH1) in both adults and children. PH1 is a rare genetic condition where your body produces too much oxalate, a substance that can form painful kidney stones and damage your kidneys over time.

In people with PH1, a genetic mutation causes the liver to overproduce oxalate because it lacks a crucial enzyme called alanine-glyoxylate aminotransferase (AGT). Without this enzyme working properly, substances that should be safely processed instead get converted into oxalate. This excess oxalate then travels through your bloodstream to your kidneys, where it can crystallize and form stones.

The condition can lead to serious complications if left untreated. These include recurrent kidney stones, kidney damage, kidney failure, and in severe cases, a condition called systemic oxalosis where oxalate crystals deposit in other organs like the heart, bones, and eyes. Lumasiran helps prevent these complications by addressing the underlying cause of excess oxalate production.

How Does Lumasiran Work?

Lumasiran works through a sophisticated process called RNA interference, which essentially tells your liver cells to stop making so much oxalate. The medication targets and silences the LDHA gene, which is responsible for producing an enzyme that contributes to oxalate formation.

When you receive a lumasiran injection, the medication travels to your liver where it binds to specific messenger RNA molecules. These molecules normally carry instructions for making proteins that lead to oxalate production. By interfering with these messages, lumasiran effectively reduces the amount of oxalate your body creates by up to 65% or more.

This is considered a moderately strong medication in terms of its effectiveness, but it's also highly targeted. Unlike some treatments that affect multiple body systems, lumasiran specifically focuses on the liver cells responsible for excess oxalate production. The effects of each injection can last for several months, which is why you don't need daily dosing like with many other medications.

How Should I Take Lumasiran?

Lumasiran is given as a subcutaneous injection, which means it's injected into the fatty tissue just under your skin. Your healthcare provider will teach you or a family member how to give these injections safely at home, though some people prefer to have them done at a medical facility.

The injection is typically given in areas where you have adequate subcutaneous fat, such as your thigh, upper arm, or abdomen. You'll rotate injection sites to prevent irritation or scarring in any one area. The medication comes in pre-filled syringes or vials that need to be kept refrigerated until use.

Unlike oral medications, you don't need to worry about taking lumasiran with food or on an empty stomach since it's injected. However, you should let the medication come to room temperature for about 30 minutes before injection to make it more comfortable. Your doctor will provide detailed instructions on proper injection technique, storage, and disposal of used needles and syringes.

How Long Should I Take Lumasiran For?

Lumasiran is typically a long-term treatment that you'll likely need to continue indefinitely. Since PH1 is a genetic condition, your body will continue to overproduce oxalate without ongoing treatment to keep it in check.

The initial treatment schedule usually involves more frequent injections to quickly reduce your oxalate levels, followed by maintenance dosing every three months. Your doctor will monitor your urine oxalate levels regularly to ensure the medication is working effectively and may adjust your dosing schedule based on your individual response.

Most people start seeing reductions in their urine oxalate levels within the first month of treatment, with maximum effects typically achieved after several months of consistent dosing. Your healthcare team will work with you to establish a long-term treatment plan that fits your lifestyle while providing optimal disease management.

What Are the Side Effects of Lumasiran?

Like all medications, lumasiran can cause side effects, though many people tolerate it well. The most common side effects are generally mild and related to the injection itself rather than systemic effects throughout your body.

The most frequently reported side effects include reactions at the injection site, such as redness, swelling, itching, or mild pain where the needle was inserted. These reactions are usually temporary and resolve on their own within a few days. Some people also experience mild flu-like symptoms, including fatigue, headache, or muscle aches, particularly after their first few injections.

Less common but more concerning side effects can include allergic reactions, though these are rare. Signs of a serious allergic reaction might include difficulty breathing, severe swelling of your face or throat, or widespread rash. If you experience any of these symptoms, seek immediate medical attention.

Some people may experience changes in their liver function tests, which is why your doctor will monitor these levels regularly. Rarely, people might develop kidney problems, though this is more often related to the underlying PH1 condition rather than the medication itself. Your healthcare team will carefully monitor your kidney function throughout treatment.

Who Should Not Take Lumasiran?

Lumasiran is specifically designed for people with primary hyperoxaluria type 1, so it's not appropriate for other types of kidney stone diseases or hyperoxaluria conditions. Your doctor will confirm your PH1 diagnosis through genetic testing before prescribing this medication.

People with severe allergies to lumasiran or any of its components should not use this medication. If you have a history of serious allergic reactions to other injectable medications, make sure to discuss this thoroughly with your healthcare provider before starting treatment.

If you have severe liver disease or significantly impaired liver function, your doctor may need to carefully evaluate whether lumasiran is appropriate for you, since the medication works primarily in the liver. Similarly, if you have severe kidney disease or are on dialysis, your treatment plan may need special consideration.

Pregnant or breastfeeding women should discuss the risks and benefits of lumasiran with their healthcare provider, as there's limited data on its safety during pregnancy and lactation. Your doctor will help weigh the potential benefits against any possible risks to you and your baby.

Lumasiran Brand Name

Lumasiran is marketed under the brand name Oxlumo in the United States and many other countries. This brand name was chosen to reflect the medication's purpose of reducing oxalate levels in people with primary hyperoxaluria.

Oxlumo is manufactured by Alnylam Pharmaceuticals, a company that specializes in RNA interference therapeutics. The medication received FDA approval in 2020, making it the first approved treatment specifically designed to address the underlying cause of PH1 rather than just managing its symptoms.

When discussing your treatment with healthcare providers or insurance companies, they may refer to the medication by either its generic name (lumasiran) or its brand name (Oxlumo). Both names refer to the same medication, so don't be confused if you hear different terms used interchangeably.

Lumasiran Alternatives

Before lumasiran became available, treatment options for PH1 were limited and primarily focused on managing symptoms rather than addressing the underlying cause. Traditional approaches included high fluid intake, dietary oxalate restriction, and medications like potassium citrate to help prevent stone formation.

For people with severe PH1 who developed kidney failure, liver transplantation was often the only definitive treatment option. A liver transplant can cure PH1 because it replaces the defective liver cells with healthy ones that produce the missing enzyme. However, transplantation carries significant risks and requires lifelong immunosuppressive medications.

Some people with PH1 may also benefit from combined liver-kidney transplantation if they have both liver disease and kidney failure. However, these procedures are complex and not suitable for everyone. The availability of lumasiran has significantly changed the treatment landscape, offering a less invasive option that can prevent the need for transplantation in many cases.

Supportive treatments like increased fluid intake, dietary modifications, and medications to alkalinize urine may still be used alongside lumasiran to provide comprehensive care for people with PH1.

Is Lumasiran Better Than Other PH1 Treatments?

Lumasiran represents a significant advancement over traditional PH1 treatments because it's the first medication that directly targets the underlying cause of the condition rather than just managing its symptoms. Unlike dietary restrictions and increased fluid intake, which provide modest benefits, lumasiran can reduce oxalate production by 65% or more.

Compared to liver transplantation, lumasiran offers a much less invasive treatment option with fewer risks and complications. While liver transplantation can cure PH1, it requires major surgery, lifelong immunosuppressive medications, and carries risks of rejection and other serious complications. Lumasiran allows people to manage their condition effectively while maintaining their quality of life.

The medication also offers advantages over symptom-based treatments like potassium citrate or increased fluid intake. While these approaches can help prevent stone formation to some degree, they don't address the root cause of excess oxalate production. Lumasiran provides more comprehensive disease management by reducing the amount of oxalate your body produces in the first place.

However, the best treatment approach depends on your individual circumstances, including the severity of your condition, your overall health, and your personal preferences. Your healthcare team will work with you to determine the most appropriate treatment plan for your specific situation.